Evidence map›Paper›PMID 42232867›Full record

ArticleChemical science2026

Rethinking peptide developability with sequence-only models: interpretable screening of microplastic-binding peptides with gated query pooling.

Guangyao Chen, Fengqi You

Abstract read
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Guangyao ChenCollege of Engineering, Cornell University Ithaca NY 14853 USA fengqi.you@cornell.edu.
Fengqi YouCollege of Engineering, Cornell University Ithaca NY 14853 USA fengqi.you@cornell.edu.ORCID https://orcid.org/0000-0001-9609-4299

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Designing peptides for microplastic targeting is intrinsically multi-objective: sequence motifs that promote adsorption to hydrophobic polymers frequently elevate developability risks, including hemolysis, non-specific adsorption, and poor aqueous solubility. In this paper, we show that accurate developability screening can be achieved from sequence alone by focusing on the readout that converts token-level foundation model representations into peptide-level decisions. We introduce gated query pooling (GQP), a lightweight, backbone-agnostic evidence-selection head that learns a small set of query vectors to extract complementary signals from protein language model embeddings and gates them adaptively per peptide. With a consistent evaluation protocol and identical splits for all methods, GQP with sequence-only backbones reaches 91.09%, 86.30%, and 75.56% accuracy on hemolysis, non-fouling, and solubility, respectively, outperforming representative sequence-only and AlphaFold-augmented Multi-Peptide baselines. Beyond predictive accuracy, attention diagnostics and controlled counterfactual substitutions enable residue-level, testable design rules that connect model outputs to actionable sequence edits. Finally, integrating these developability constraints with PepBD-derived affinity scores for polyethylene, polypropylene, and polyethylene terephthalate supports scalable multi-objective prioritization of microplastic-binding candidates and reveals non-fouling as a dominant feasibility bottleneck, with coarse-grained molecular dynamics triage providing complementary physical evidence supporting the plausibility of the PepBD-prioritized selections.

Identifiers

PMID42232867
PMCPMC13223611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.